Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors

Clinical trial NCT03302403 · UNKNOWN

Trial details

NCT number: NCT03302403
Sponsor: Kang YU
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

B Cell Lymphoma B Cell Leukemia Myeloma Hepatocellular Carcinoma Pancreatic Carcinoma Adenocarcinoma of Esophagogastric Junction

Start date: 2017-12-29
Primary completion: 2020-12-12
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.